RxDoctor Payments Data

David Hoopes, MD

Radiation Oncology · San Diego, CANPI 1962520080

Payments from drug & device makers

$6,348in general payments, 2019–2025

Across 275 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$695
  • Johnson & Johnson$474
  • Merck$455
  • Novartis$385
  • Daiichi Sankyo Inc.$262
  • Pharmacyclics LLC, An Abbvie Company$241
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$6,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)27$695
Johnson & Johnson22$474
Merck22$455
Novartis19$385
Daiichi Sankyo Inc.12$262
Pharmacyclics LLC, An Abbvie Company11$241
Coherus Oncology, Inc.11$220
Pfizer9$206
Incyte Corporation9$205
Beigene USA, Inc.7$194
Regeneron Healthcare Solutions, Inc.6$175
Seagen Inc.6$158
Puma Biotechnology, Inc.6$156
Ipsen Biopharmaceuticals, Inc7$144
Tersera Therapeutics LLC4$136
Pharmaessentia USA Corporation4$135
Bayer7$123
Eisai Inc.5$122
Blueprint Medicines Corporation5$121
Amgen4$99
Takeda Pharmaceuticals U.S.A., Inc.4$92
Boehringer Ingelheim3$86
Taiho Oncology, Inc.3$85
Verity Pharmaceuticals Inc.3$71
Rigel Pharmaceuticals, Inc.2$64
ADC Therapeutics America, Inc.2$54
EUSA Pharma (US) LLC3$53
E.r. Squibb & Sons, L.L.C.3$52
Acrotech Biopharma Inc.3$50
Sun Pharmaceutical Industries Inc.2$46
AVEO Pharmaceuticals, Inc.2$42
Fresenius Kabi USA, LLC2$41
Novocure Inc.2$40
Servier Pharmaceuticals LLC2$40
Exelixis Inc.2$39
GSK2$39
Octapharma USA, Inc.2$37
Dendreon Pharmaceuticals LLC1$35
Foundation Medicine, Inc.2$34
Sanofi1$34
Blue Earth Diagnostics1$34
Macrogenics, Inc.1$33
Lilly USA, LLC2$31
CTI Biopharma Corp.1$29
Catalyst Pharmaceuticals, Inc.1$29
Stemline Therapeutics Inc.1$28
Menarini Silicon Biosystems, Inc.1$27
Tempus AI, Inc1$26
AbbVie1$26
Deciphera Pharmaceuticals Inc.1$26
Gilead1$26
EMD Serono, Inc.1$25
Epizyme, Inc.1$24
Recordati_rare_diseases_inc.1$23
Pharmacosmos Therapeutics Inc.1$23
Bristol Myers Squibb1$23
Heron Therapeutics, Inc.1$22
Secura Bio, Inc.1$21
Sobi, Inc1$20
Accord Healthcare, Inc.1$20

How this compares

$6,348 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$405,965
Medicare patients
99
Services billed
1,332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate48$2,009
Tamsulosin Hcl22$437

Paid to pharmacies, not to this prescriber.

Other radiation oncology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →